Category: Technology Licenses
Created On: 2022-04-28
Record Count: 6
- Diagnostic Substances
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 1713
IPSCIO Record ID: 378
U.S. Patent 5,120,310, Issued June 9, 1992, entitled Nonreusable Syringe; U.S. Patent 5,188,613, Issued February 23, 1993, entitled Nonreusable Syringe with Safety Clip; U.S. Patent 5,267,961, Issued December 7, 1993, entitled Nonreusable Syringe with Safety Clip; Foreign Counterpart Patent Applications on the Nonreusable Syringe with Safety Clip corresponding to U.S. Patents 5,120,310 and 5,188,613 for Europe (Serial No. 92910361.2), China (Serial No. 92102245.X), India (Serial No. 186/CAL/92), Mexico (Serial No. 92-01493), and Taiwan (Serial No. 82205282); U.S. Patent 5,423,758, Issued June 13, 1995, Entitled Retractable Fluid Collection Device and a Counterpart Patent Cooperation Treaty Application Serial No. 94/13953, Entitled Blood Sampler, Filed December 6, 1994 designating all PCT countries; U.S. Patent 5,385,551, Issued January 31, 1995, Entitled Nonreusable Syringe with Front Retraction and a Counterpart Patent Cooperation Treaty Application Serial No. PCT/US94/10235, Filed September 7, 1994 designating all PCT countries; U.S. Patent 5,389,076, Issued February 14, 1995, Entitled Single Use Medical Device with Retraction Mechanism and a Counterpart Patent Cooperation Treaty Application Serial No. PCT/US95/03953, Filed March 31, 1995 designating all PCT countries; U.S. Patent Application Serial No. 380107, Filed January 30, 1995, Entitled Syringe Plunger Seal and Locking Assembly, and the right to file Patent Applications thereon in nearly any foreign country until January 30, 1996; and A new U.S. Patent Application filed in May, 1995, Entitled Tamperproof Retractable Syringe with Serial No. 08/438,954, and the right to file Patent Applications thereon in nearly any foreign country until May, 1996.
IPSCIO Record ID: 1233
Licensor grants to an exclusive right and license in and to all of its right, title and interest in and to the Hematocrit Technology and any derivative thereof, to make, have made, use, sell, offer to sell, and import Products and to practice methods covered by or included in the Hematocrit Technology for the life of any protectable rights in the Hematocrit Technology.
Licensor's application for a patent entitled 'Method and Apparatus for Non-Invasively Determining Hematocrit' was allowed by the U.S. Patent and Trademark Office, and such patent issued on June 18, 1996, as Patent No. 5,526,808 with a term of 17 years and an expiration date of June 18, 2013. Licensor has been issued three additional patents, Patent No. 5,642,734, Patent No. 6,128,518 and Patent No. 6,766,191, each of which claims priority from October 4, 1990, the date of the first patent's filing, and each of which has an
expiration date of October 4, 2010.
IPSCIO Record ID: 2281
Licensed Methods shall mean (i) any method that i-STAT has used for determining hematocrit in its commercially-available analyzers from the issuance of the Patent through and including December 31, 2000, including, but not limited to, any method for determining hematocrit used in the i-STAT(R) System, the i-STAT(R) Portable Clinical Analyzer, or the i-STAT 1; and (ii) any method for determining hematocrit claimed in the Patent.
IPSCIO Record ID: 3240
The Licensor also granted the Licensee a non-exclusive, perpetual and worldwide license, with sublicense rights, to use Masimo SETÂ® for the measurement of vital signs in the Licensee Market.
Pursuant to the Cross-Licensing Agreement, the Licensor has licensed from the Licensee the right to make and distribute products in the Licensor Market that utilize rainbowÂ® technology for the measurement of only carbon monoxide, methemoglobin, fractional arterial oxygen saturation and hemoglobin, which includes hematocrit
RainbowÂ® SET platform utilizing both Masimo SETÂ® and licensed rainbowÂ® technology, includes devices cleared by the U.S. Food and Drug Administration, to noninvasively and continuously monitor multiple measurements that previously required invasive or complicated procedures.
IPSCIO Record ID: 28337